Sincalide
NDC 70511-131, Sincalide, injection, powder, lyophilized, for solution, from MAIA Pharmaceuticals, Inc..
- Product NDC
- 70511-131
- Status
- Listed
- Labeler
- MAIA Pharmaceuticals, Inc.
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA210850
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70511-131 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SINCALIDE5 ug/5mL
Pharmacologic classes
Cholecystokinin Analog [EPC]; Cholecystokinin [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70511-131-84 | 70511013184 | 10 VIAL in 1 PACKAGE (70511-131-84) / 5 mL in 1 VIAL (70511-131-05) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/4149af34-7b3d-4200-9609-ea856b1d6aab
Use it
Look up 70511-131 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70511-131 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70511-131. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.